Keywords

• 14605-22-2 factory
• Tauroursodeoxycholic acid Wholesaler
• Tudca 14605-22-2

Quick Details

• ProName: 14605-22-2 factory Tauroursodeoxychol...
• CasNo: 14605-22-2
• Molecular Formula: C26H45NO6S
• Appearance: White powder
• Application: Health care grade,API,
• DeliveryTime: 5-7 working days
• PackAge: Bottle, Drum, Vacuum Packed, Plastic b...
• Port: China major port
• ProductionCapacity: 55 Metric Ton/Day
• Purity: 99%
• Storage: Sealed, dry and refrigerated
• Transportation: By Express,Air,Sea
• LimitNum: 50 Gram
• Related Substances: Tauroursodeoxycholic acid
• Residue on Ignition: <5
• Heavy Metal: <10ppm
• Valid Period: 2 Years
• Active Ingredient: DeoxycholateTauroursodeoxycholic acid
• Specification: 99%
• Einecs No.: 1308068-626-2
• Application: Health care grade，API
• Sample: 5-10g
• MOQ: 1KG
• Place of Origin: Shaanxi， China
• Brand Name: QUANAO

Superiority

14605-22-2 factory  Tauroursodeoxycholic acid  Wholesaler Tudca

Taurine deoxycholic acid is a natural bile acid isolated from bear bile. It is a chemical preparation. It is a hydrophilic cholic acid and a cholesterol stone dissolving agent. It can reduce the secretion of cholesterol in liver, reduce the saturation of cholesterol in bile, promote the secretion of bile acid, increase the solubility of cholesterol in bile, dissolve cholesterol stones or prevent the formation of stones. It can increase the amount of bile secretion and relax the sphincter of bile duct to produce cholinergic effect, which is beneficial to the excretion of stones. This product can not dissolve other types of gallstones. It is suitable for the treatment of cholesterol stones, hyperlipidemia, bile secretion disorders, primary biliary cirrhosis, chronic hepatitis, bile reflux gastritis and prevention of acute

Tauroursodeoxycholic acid[TUDCA], the more hydrophilic form of ursodeoxycholic acid[UDCA], is the more abundant naturally produced bile acid in humans. Moreover, tauroursodeoxycholic acid is found in bears with high amount and has been used for centuries as a natural remedy in some Asian countries. It has been approved in Italy and Turkey for the treatment of cholesterol gallstones and as well as being investigational drug in China, Unites States, and Italy. Tauroursodeoxycholic acid is also under investigation of its potential therapeutic effects on Primary Biliary Cirrhosis[PBC], insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis. The only completed clinical trial thus far is a phase III clinical trial comparing tauroursodeoxycholic acid and ursofalk in PBC adult patients, but as of June 2013 no results of this trial have been published.

Tauroursodeoxycholic acid is intended for Pharmaceuticals applications. All information about Tauroursodeoxycholic acid sodium salt is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

Details